• Inspire Medical Systems, Inc. to Report Third Quarter 2023 Financial Results on November 7, 2023

    Source: Nasdaq GlobeNewswire / 03 Oct 2023 07:00:00   America/Chicago

    MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2023 after the close of trading on Tuesday, November 7. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

    A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q3 2023 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

    If you plan to ask a question, please use the following link: Inspire's Q3 2023 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

    Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

    About Inspire Medical Systems
    Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

    For additional information about Inspire, please visit www.inspiresleep.com.

    Investor and Media Contact
    Ezgi Yagci
    Vice President, Investor Relations
    ezgiyagci@inspiresleep.com
    617-549-2443


    Primary Logo

Share on,